1. Home
  2. CENX vs CRSP Comparison

CENX vs CRSP Comparison

Compare CENX & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Aluminum Company

CENX

Century Aluminum Company

N/A

Current Price

$57.76

Market Cap

4.0B

Sector

Industrials

ML Signal

N/A

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

N/A

Current Price

$48.70

Market Cap

4.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CENX
CRSP
Founded
1995
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Aluminum
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.7B
IPO Year
2004
2016

Fundamental Metrics

Financial Performance
Metric
CENX
CRSP
Price
$57.76
$48.70
Analyst Decision
Strong Buy
Buy
Analyst Count
3
17
Target Price
$54.33
$70.00
AVG Volume (30 Days)
2.3M
1.7M
Earning Date
01-01-0001
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.42
N/A
Revenue
$1,893,200,000.00
$289,590,000.00
Revenue This Year
$11.48
$1,070.60
Revenue Next Year
$12.88
$100.28
P/E Ratio
$138.26
N/A
Revenue Growth
N/A
9169.85
52 Week Low
$13.05
$30.06
52 Week High
$58.10
$78.48

Technical Indicators

Market Signals
Indicator
CENX
CRSP
Relative Strength Index (RSI) 64.67 39.67
Support Level $27.33 $46.78
Resistance Level N/A $60.63
Average True Range (ATR) 3.32 3.33
MACD 0.28 -0.94
Stochastic Oscillator 86.59 2.84

Price Performance

Historical Comparison
CENX
CRSP

About CENX Century Aluminum Company

Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: